_id
690f3d2cccc777a4e85d1a8b
Ticker
CDTTW
Name
Conduit Pharmaceuticals Inc.
Exchange
NASDAQ
Address
4581 Tamiami Trail North, Naples, FL, United States, 34103
Country
USA
Sector
Industry
Currency
USD
Website
https://www.conduitpharma.com
Description
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Last Close
0.0119
Volume
34000
Current Price
0.007
Change
-0.0019
Last Updated
2026-01-02T11:07:59.665Z
Image
data:image/webp;base64,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
Ipo Date
2023-09-25T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
698221000
Cost Of Revenue
885000
Gross Profit
-885000
Operating Expenses
6148000
Operating Income
-7033000
Interest Expense
48000
Pretax Income
-7215000
Net Income
-7118000
Eps
-0.17652018648943557
Dividends Per Share
1976000
Shares Outstanding
0
Income Tax Expense
-97000
EBITDA
-6282000
Operating Margin
-1.0072742011483469
Total Other Income Expense Net
-182000
Cash
3838000
Short Term Investments
990000
Receivables
398000
Inventories
393911000
Total Current Assets
7094000
Property Plant Equipment
519000
Total Assets
8552000
Payables
613000
Short Term Debt
1867000
Long Term Debt
-
Total Liabilities
4274000
Equity
4278000
Bs_currency_symbol
USD
Depreciation
33563000
Change In Working Capital
-342000
Cash From Operations
105006000
Capital Expenditures
39681000
Cash From Investing
-39802000
Cash From Financing
-54164000
Net Change In Cash
12771000
Cf_currency_symbol
USD
PE
-
PB
0.06598129967274427
ROE
-166.38616175783076
ROA
-83.23199251637044
FCF
65325000
Fcf Percent
0.09355920260204148
Piotroski FScore
2
Health Score
38
Deep Value Investing Score
5.5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
3.5
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
3
Quality Investing Score
4
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
698221000
Quarters > 0 > income Statement > cost Of Revenue
885000
Quarters > 0 > income Statement > gross Profit
-885000
Quarters > 0 > income Statement > operating Expenses
6148000
Quarters > 0 > income Statement > operating Income
-7033000
Quarters > 0 > income Statement > interest Expense
48000
Quarters > 0 > income Statement > pretax Income
-7215000
Quarters > 0 > income Statement > net Income
-7118000
Quarters > 0 > income Statement > eps
-0.17652018648943557
Quarters > 0 > income Statement > dividends Per Share
1976000
Quarters > 0 > income Statement > shares Outstanding
40324000
Quarters > 0 > income Statement > income Tax Expense
-97000
Quarters > 0 > income Statement > EBITDA
-6282000
Quarters > 0 > income Statement > operating Margin
-1.0072742011483469
Quarters > 0 > income Statement > total Other Income Expense Net
-182000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
3838000
Quarters > 0 > balance Sheet > short Term Investments
990000
Quarters > 0 > balance Sheet > receivables
398000
Quarters > 0 > balance Sheet > inventories
393911000
Quarters > 0 > balance Sheet > total Current Assets
7094000
Quarters > 0 > balance Sheet > property Plant Equipment
519000
Quarters > 0 > balance Sheet > total Assets
8552000
Quarters > 0 > balance Sheet > payables
613000
Quarters > 0 > balance Sheet > short Term Debt
1867000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4274000
Quarters > 0 > balance Sheet > equity
4278000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
56690000
Quarters > 0 > cash Flow > depreciation
33563000
Quarters > 0 > cash Flow > change In Working Capital
-342000
Quarters > 0 > cash Flow > cash From Operations
105006000
Quarters > 0 > cash Flow > capital Expenditures
39681000
Quarters > 0 > cash Flow > cash From Investing
-39802000
Quarters > 0 > cash Flow > cash From Financing
-54164000
Quarters > 0 > cash Flow > net Change In Cash
12771000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.17652018648943557
Quarters > 0 > ratios > PB
0.06598129967274427
Quarters > 0 > ratios > ROE
-166.38616175783076
Quarters > 0 > ratios > ROA
-83.23199251637044
Quarters > 0 > ratios > FCF
65325000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.09355920260204148
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
671992000
Quarters > 1 > income Statement > cost Of Revenue
828000
Quarters > 1 > income Statement > gross Profit
-828000
Quarters > 1 > income Statement > operating Expenses
4952000
Quarters > 1 > income Statement > operating Income
-4952000
Quarters > 1 > income Statement > interest Expense
57000
Quarters > 1 > income Statement > pretax Income
-6028000
Quarters > 1 > income Statement > net Income
-6028000
Quarters > 1 > income Statement > eps
-0.15069246537673117
Quarters > 1 > income Statement > dividends Per Share
2007000
Quarters > 1 > income Statement > shares Outstanding
40002000
Quarters > 1 > income Statement > income Tax Expense
-5666000
Quarters > 1 > income Statement > EBITDA
-5143000
Quarters > 1 > income Statement > operating Margin
-0.7369135346849367
Quarters > 1 > income Statement > total Other Income Expense Net
-1076000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
3332000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
245000
Quarters > 1 > balance Sheet > inventories
388787000
Quarters > 1 > balance Sheet > total Current Assets
6386000
Quarters > 1 > balance Sheet > property Plant Equipment
585000
Quarters > 1 > balance Sheet > total Assets
7989000
Quarters > 1 > balance Sheet > payables
1253000
Quarters > 1 > balance Sheet > short Term Debt
2020000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4460000
Quarters > 1 > balance Sheet > equity
3529000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6028000
Quarters > 1 > cash Flow > depreciation
828000
Quarters > 1 > cash Flow > change In Working Capital
979000
Quarters > 1 > cash Flow > cash From Operations
-2580000
Quarters > 1 > cash Flow > capital Expenditures
1000
Quarters > 1 > cash Flow > cash From Investing
-1000
Quarters > 1 > cash Flow > cash From Financing
3757000
Quarters > 1 > cash Flow > net Change In Cash
1202000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.15069246537673117
Quarters > 1 > ratios > PB
0.07934655709832814
Quarters > 1 > ratios > ROE
-170.8132615471805
Quarters > 1 > ratios > ROA
-75.45374890474402
Quarters > 1 > ratios > FCF
-2581000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.0038408195335658756
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
624861000
Quarters > 2 > income Statement > cost Of Revenue
190000
Quarters > 2 > income Statement > gross Profit
-190000
Quarters > 2 > income Statement > operating Expenses
3616000
Quarters > 2 > income Statement > operating Income
-3616000
Quarters > 2 > income Statement > interest Expense
176000
Quarters > 2 > income Statement > pretax Income
-4753000
Quarters > 2 > income Statement > net Income
-4753000
Quarters > 2 > income Statement > eps
-2.3273920282048772
Quarters > 2 > income Statement > dividends Per Share
2017000
Quarters > 2 > income Statement > shares Outstanding
2042200
Quarters > 2 > income Statement > income Tax Expense
-10144000
Quarters > 2 > income Statement > EBITDA
-4380000
Quarters > 2 > income Statement > operating Margin
-0.5786887003669616
Quarters > 2 > income Statement > total Other Income Expense Net
-1137000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2130000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
488000
Quarters > 2 > balance Sheet > inventories
373045000
Quarters > 2 > balance Sheet > total Current Assets
5949000
Quarters > 2 > balance Sheet > property Plant Equipment
621767000
Quarters > 2 > balance Sheet > total Assets
7321000
Quarters > 2 > balance Sheet > payables
307057000
Quarters > 2 > balance Sheet > short Term Debt
2789000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
4634000
Quarters > 2 > balance Sheet > equity
2687000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
51937000
Quarters > 2 > cash Flow > depreciation
29784000
Quarters > 2 > cash Flow > change In Working Capital
-1211000
Quarters > 2 > cash Flow > cash From Operations
7441000
Quarters > 2 > cash Flow > capital Expenditures
32202000
Quarters > 2 > cash Flow > cash From Investing
-24178000
Quarters > 2 > cash Flow > cash From Financing
-96784000
Quarters > 2 > cash Flow > net Change In Cash
-111305000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.3273920282048772
Quarters > 2 > ratios > PB
0.005320208410867138
Quarters > 2 > ratios > ROE
-176.88872348343878
Quarters > 2 > ratios > ROA
-64.92282475071711
Quarters > 2 > ratios > FCF
-24761000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.03962641291423213
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1076964000
Quarters > 3 > income Statement > cost Of Revenue
452000
Quarters > 3 > income Statement > gross Profit
-452000
Quarters > 3 > income Statement > operating Expenses
3061000
Quarters > 3 > income Statement > operating Income
-3513000
Quarters > 3 > income Statement > interest Expense
960000
Quarters > 3 > income Statement > pretax Income
-2406000
Quarters > 3 > income Statement > net Income
-2406000
Quarters > 3 > income Statement > eps
-1.1651613840528827
Quarters > 3 > income Statement > dividends Per Share
6120000
Quarters > 3 > income Statement > shares Outstanding
2064950
Quarters > 3 > income Statement > income Tax Expense
10000
Quarters > 3 > income Statement > EBITDA
-994000
Quarters > 3 > income Statement > operating Margin
-0.32619474745673954
Quarters > 3 > income Statement > total Other Income Expense Net
1107000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
554000
Quarters > 3 > balance Sheet > short Term Investments
369748000
Quarters > 3 > balance Sheet > receivables
489000
Quarters > 3 > balance Sheet > inventories
343099000
Quarters > 3 > balance Sheet > total Current Assets
1196229000
Quarters > 3 > balance Sheet > property Plant Equipment
614176000
Quarters > 3 > balance Sheet > total Assets
4193000
Quarters > 3 > balance Sheet > payables
1428000
Quarters > 3 > balance Sheet > short Term Debt
7350000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
10986000
Quarters > 3 > balance Sheet > equity
-6793000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2406000
Quarters > 3 > cash Flow > depreciation
452000
Quarters > 3 > cash Flow > change In Working Capital
-2415000
Quarters > 3 > cash Flow > cash From Operations
-3813000
Quarters > 3 > cash Flow > capital Expenditures
80327000
Quarters > 3 > cash Flow > cash From Investing
85000
Quarters > 3 > cash Flow > cash From Financing
4210000
Quarters > 3 > cash Flow > net Change In Cash
483000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.1651613840528827
Quarters > 3 > ratios > PB
-0.002127874282349477
Quarters > 3 > ratios > ROE
35.41881348446931
Quarters > 3 > ratios > ROA
-57.381349868829
Quarters > 3 > ratios > FCF
-84140000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.07812703117281543
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
922222000
Annuals > 0 > income Statement > cost Of Revenue
457000
Annuals > 0 > income Statement > gross Profit
-457000
Annuals > 0 > income Statement > operating Expenses
14962000
Annuals > 0 > income Statement > operating Income
-15419000
Annuals > 0 > income Statement > interest Expense
1506000
Annuals > 0 > income Statement > pretax Income
-17802000
Annuals > 0 > income Statement > net Income
-17802000
Annuals > 0 > income Statement > eps
-8.62103198624664
Annuals > 0 > income Statement > dividends Per Share
8195000
Annuals > 0 > income Statement > shares Outstanding
2064950
Annuals > 0 > income Statement > income Tax Expense
-29528000
Annuals > 0 > income Statement > EBITDA
-15839000
Annuals > 0 > income Statement > operating Margin
-1.671940161913292
Annuals > 0 > income Statement > total Other Income Expense Net
-2383000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
554000
Annuals > 0 > balance Sheet > short Term Investments
369748000
Annuals > 0 > balance Sheet > receivables
489000
Annuals > 0 > balance Sheet > inventories
343099000
Annuals > 0 > balance Sheet > total Current Assets
2715000
Annuals > 0 > balance Sheet > property Plant Equipment
303000
Annuals > 0 > balance Sheet > total Assets
4193000
Annuals > 0 > balance Sheet > payables
1428000
Annuals > 0 > balance Sheet > short Term Debt
7350000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
10986000
Annuals > 0 > balance Sheet > equity
-6793000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-17802000
Annuals > 0 > cash Flow > depreciation
457000
Annuals > 0 > cash Flow > change In Working Capital
-142000
Annuals > 0 > cash Flow > cash From Operations
-9682000
Annuals > 0 > cash Flow > capital Expenditures
51000
Annuals > 0 > cash Flow > cash From Investing
-43000
Annuals > 0 > cash Flow > cash From Financing
6067000
Annuals > 0 > cash Flow > net Change In Cash
-3674000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-8.62103198624664
Annuals > 0 > ratios > PB
-0.0016719012218460178
Annuals > 0 > ratios > ROE
262.06388929780655
Annuals > 0 > ratios > ROA
-424.56475077510134
Annuals > 0 > ratios > FCF
-9733000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.010553857964785052
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
5262000
Annuals > 1 > income Statement > operating Income
-5262000
Annuals > 1 > income Statement > interest Expense
211000
Annuals > 1 > income Statement > pretax Income
2842000
Annuals > 1 > income Statement > net Income
-535000
Annuals > 1 > income Statement > eps
-0.3151972191946269
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1697350
Annuals > 1 > income Statement > income Tax Expense
-168000
Annuals > 1 > income Statement > EBITDA
3053000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
8104000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4228000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5733000
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
7224000
Annuals > 1 > balance Sheet > payables
215000
Annuals > 1 > balance Sheet > short Term Debt
985000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
7681000
Annuals > 1 > balance Sheet > equity
-457000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-535000
Annuals > 1 > cash Flow > depreciation
0
Annuals > 1 > cash Flow > change In Working Capital
-2516000
Annuals > 1 > cash Flow > cash From Operations
-7725000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
725000
Annuals > 1 > cash Flow > cash From Financing
10929000
Annuals > 1 > cash Flow > net Change In Cash
4228000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.3151972191946269
Annuals > 1 > ratios > PB
-0.02042762582056893
Annuals > 1 > ratios > ROE
117.06783369803064
Annuals > 1 > ratios > ROA
-7.405869324473975
Annuals > 1 > ratios > FCF
-7725000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
3160000
Annuals > 2 > income Statement > operating Income
-3160000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-4887000
Annuals > 2 > income Statement > net Income
-4887000
Annuals > 2 > income Statement > eps
-1.349664448065398
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3620900
Annuals > 2 > income Statement > income Tax Expense
374862
Annuals > 2 > income Statement > EBITDA
-4887000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1727000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
345777
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
646639
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
5000
Annuals > 2 > balance Sheet > payables
0
Annuals > 2 > balance Sheet > short Term Debt
175000
Annuals > 2 > balance Sheet > long Term Debt
2010000
Annuals > 2 > balance Sheet > total Liabilities
10094000
Annuals > 2 > balance Sheet > equity
-10089000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-4887000
Annuals > 2 > cash Flow > depreciation
1727000
Annuals > 2 > cash Flow > change In Working Capital
596000
Annuals > 2 > cash Flow > cash From Operations
-2266000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-183000
Annuals > 2 > cash Flow > cash From Financing
2448000
Annuals > 2 > cash Flow > net Change In Cash
-48555
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.349664448065398
Annuals > 2 > ratios > PB
-0.001973927049261572
Annuals > 2 > ratios > ROE
48.43889384478145
Annuals > 2 > ratios > ROA
-97740
Annuals > 2 > ratios > FCF
-2266000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
3173000
Annuals > 3 > income Statement > operating Income
-3173000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-3657000
Annuals > 3 > income Statement > net Income
-3657000
Annuals > 3 > income Statement > eps
-6347.305389221558
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
576.15
Annuals > 3 > income Statement > income Tax Expense
247442
Annuals > 3 > income Statement > EBITDA
-3173000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-484000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
48555
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
104163
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
213125
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
177057
Annuals > 3 > balance Sheet > long Term Debt
749000
Annuals > 3 > balance Sheet > total Liabilities
192506
Annuals > 3 > balance Sheet > equity
20619
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3657000
Annuals > 3 > cash Flow > depreciation
484000
Annuals > 3 > cash Flow > change In Working Capital
1357000
Annuals > 3 > cash Flow > cash From Operations
-2151000
Annuals > 3 > cash Flow > capital Expenditures
5
Annuals > 3 > cash Flow > cash From Investing
48555
Annuals > 3 > cash Flow > cash From Financing
1898000
Annuals > 3 > cash Flow > net Change In Cash
-252000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-6347.305389221558
Annuals > 3 > ratios > PB
0.000153684708278772
Annuals > 3 > ratios > ROE
-17736.068674523496
Annuals > 3 > ratios > ROA
-1715.8944281524928
Annuals > 3 > ratios > FCF
-2151005
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
15
Valuation > metrics > PE
-0.17652018648943557
Valuation > metrics > PB
0.06598129967274427
Valuation > final Score
70
Valuation > verdict
93.4% Undervalued
Profitability > metrics > ROE
-166.38616175783076
Profitability > metrics > ROA
-100.33831406822667
Profitability > metrics > Net Margin
-0.010194479971241198
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9990649836372136
Risk > metrics > Interest Coverage
-146.52083333333334
Risk > final Score
-538
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.860483870967742
Liquidity > metrics > Quick Ratio
-155.97459677419354
Liquidity > final Score
-7749
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
40
Prev Risks > 0
-318
Prev Risks > 1
-52
Prev Risks > 2
15
Prev Liquidities > 0
-5793
Prev Liquidities > 1
-49
Prev Liquidities > 2
100
Updated At
2026-01-20T21:34:44.988Z
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARevenue Check: Can FWONA expand its profit margins - July 2025 Earnings & Daily Profit Focused Screening baoquankhu1.vn
Read more →Why pension funds invest in Passat Société Anonyme (6JF) stock - Trade Risk Assessment & Growth Focused Stock Pick Reports bollywoodhelpline.com
Read more →Showing 2 of 9
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Medium
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Conduit Pharmaceuticals Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.